These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12865507)

  • 1. Increased cortical excitability with longer duration of Parkinson's disease as evaluated by transcranial magnetic stimulation.
    Bhatia M; Johri S; Behari M
    Neurol India; 2003 Mar; 51(1):13-5. PubMed ID: 12865507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Motor evoked potentials of transcranial magnetic stimulation for Parkinson's disease].
    Shimamoto H; Morimitsu H; Sugita S; Kimihiro N; Shigemori M; Kurihara Y
    No To Shinkei; 1996 Sep; 48(9):825-9. PubMed ID: 8888031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulation.
    Rodrigues JP; Walters SE; Stell R; Mastaglia FL; Thickbroom GW
    Neurosci Lett; 2008 Dec; 448(1):29-32. PubMed ID: 18952149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulation.
    Lefaucheur JP
    Clin Neurophysiol; 2005 Feb; 116(2):244-53. PubMed ID: 15661100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric corticomotor excitability correlations in early Parkinson's disease.
    Wu AD; Petzinger GM; Lin CH; Kung M; Fisher B
    Mov Disord; 2007 Aug; 22(11):1587-93. PubMed ID: 17523196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of the TMS in the early stages of Parkinson's disease.
    Guekht A; Selikhova M; Serkin G; Gusev E
    Electromyogr Clin Neurophysiol; 2005; 45(5):291-7. PubMed ID: 16218197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled study of rTMS for the treatment of Parkinson's disease.
    Lomarev MP; Kanchana S; Bara-Jimenez W; Iyer M; Wassermann EM; Hallett M
    Mov Disord; 2006 Mar; 21(3):325-31. PubMed ID: 16211618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS study.
    Bares M; Kanovský P; Rektor I
    Parkinsonism Relat Disord; 2007 Dec; 13(8):489-94. PubMed ID: 17449315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered corticomotor representation in patients with Parkinson's disease.
    Kagerer FA; Summers JJ; Byblow WD; Taylor B
    Mov Disord; 2003 Aug; 18(8):919-27. PubMed ID: 12889083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson's disease by cortical stimulation.
    Lefaucheur JP
    Neurophysiol Clin; 2006; 36(3):125-33. PubMed ID: 17046607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy.
    Löscher WN; Stampfer-Kountchev M; Sawires M; Seppi K; Mueller J; Szubski C; Hirnsperger K; Brenneis C; Poewe W; Wenning GK
    Mov Disord; 2007 Jan; 22(2):174-8. PubMed ID: 17133517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients.
    Cantello R; Tarletti R; Varrasi C; Cecchin M; Monaco F
    Neuroscience; 2007 Nov; 150(1):64-71. PubMed ID: 17964730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor cortex reorganisation in Parkinson's disease.
    Thickbroom GW; Byrnes ML; Walters S; Stell R; Mastaglia FL
    J Clin Neurosci; 2006 Jul; 13(6):639-42. PubMed ID: 16814549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased depressant effect of phenytoin sodium as compared to carbamazepine on cortical excitability: a transcranial magnetic evaluation.
    Goyal V; Bhatia M; Behari M
    Neurol India; 2004 Jun; 52(2):224-7. PubMed ID: 15269477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
    Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
    Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
    Hidding U; Bäumer T; Siebner HR; Demiralay C; Buhmann C; Weyh T; Moll C; Hamel W; Münchau A
    Mov Disord; 2006 Sep; 21(9):1471-6. PubMed ID: 16703590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.
    Vucic S; Kiernan MC
    Brain; 2006 Sep; 129(Pt 9):2436-46. PubMed ID: 16835248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.